Cargando…

Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial

Dendritic cells (DCs) are antigen-presenting cells that are capable of priming anti-tumor immune responses, thus serving as attractive tools to generate tumor vaccines. In this multicentric randomized open-label phase II study, we investigated the efficacy of vaccination with tumor lysate-charged au...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buchroithner, Johanna, Erhart, Friedrich, Pichler, Josef, Widhalm, Georg, Preusser, Matthias, Stockhammer, Günther, Nowosielski, Martha, Iglseder, Sarah, Freyschlag, Christian F., Oberndorfer, Stefan, Bordihn, Karin, von Campe, Gord, Hoffermann, Markus, Ruckser, Reinhard, Rössler, Karl, Spiegl-Kreinecker, Sabine, Fischer, Michael B., Czech, Thomas, Visus, Carmen, Krumpl, Günther, Felzmann, Thomas, Marosi, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210090/ https://www.ncbi.nlm.nih.gov/pubmed/30301187 http://dx.doi.org/10.3390/cancers10100372

Ejemplares similares

MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy
por: Heugenhauser, Johanna, et al.
Publicado: (2022)

Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables
por: Erhart, Friedrich, et al.
Publicado: (2018)

Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors
por: Erhart, Friedrich, et al.
Publicado: (2020)

Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma
por: Spiegl-Kreinecker, S, et al.
Publicado: (2007)

Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry
por: Woehrer, A, et al.
Publicado: (2014)

Encephalomyeloneuritis and arthritis after treatment with immune checkpoint inhibitors
por: Nowosielski, Martha, et al.
Publicado: (2020)

Whole brain radiotherapy combined with intrathecal liposomal cytarabine for leptomeningeal metastasis—a safety analysis and validation of the EANO-ESMO classification
por: Iglseder, Sarah, et al.
Publicado: (2022)

ADC textural features in patients with single brain metastases improve clinical risk models
por: Nowosielski, Martha, et al.
Publicado: (2022)

Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature
por: Erhart, Friedrich, et al.
Publicado: (2018)

Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma
por: Mair, Maximilian J., et al.
Publicado: (2020)

Clinical neuropathology practice guide 1-2013: Molecular subtyping of glioblastoma: ready for clinical use?
por: Woehrer, Adelheid, et al.
Publicado: (2013)

Dissociating Arithmetic Operations in the Parietal Cortex Using 1 Hz Repetitive Transcranial Magnetic Stimulation: The Importance of Strategy Use
por: Fresnoza, Shane, et al.
Publicado: (2020)

Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma
por: Iglseder, Sarah, et al.
Publicado: (2023)

Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational status
por: Grabner, Günther, et al.
Publicado: (2016)

An Intra-Individual Comparison of MRI, [(18)F]-FET and [(18)F]-FLT PET in Patients with High-Grade Gliomas
por: Nowosielski, Martha, et al.
Publicado: (2014)

Phosphorous Magnetic Resonance Spectroscopy to Detect Regional Differences of Energy and Membrane Metabolism in Naïve Glioblastoma Multiforme
por: Walchhofer, Lisa Maria, et al.
Publicado: (2021)

Pharmacodynamic and pharmacokinetic behavior of landiolol during dobutamine challenge in healthy adults
por: Krumpl, Günther, et al.
Publicado: (2020)

Milestones of the last 10 years: CNS cancer
por: Marosi, Christine, et al.
Publicado: (2017)

Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphoma
por: Nenning, Karl-Heinz, et al.
Publicado: (2023)

5-Aminolevulinic acid-induced protoporphyrin IX fluorescence as immediate intraoperative indicator to improve the safety of malignant or high-grade brain tumor diagnosis in frameless stereotactic biopsies
por: von Campe, Gord, et al.
Publicado: (2012)

Dobutamine Alters the Pharmacokinetic and Pharmacodynamic Behavior of Esmolol
por: Krumpl, Günther, et al.
Publicado: (2020)

Guiding Treatment Choices for Elderly Patients with Glioblastoma by a Comprehensive Geriatric Assessment
por: Lütgendorf-Caucig, Carola, et al.
Publicado: (2020)

Long interspersed element-1 ribonucleoprotein particles protect telomeric ends in alternative lengthening of telomeres dependent cells
por: Aschacher, Thomas, et al.
Publicado: (2019)

5-Aminolevulinic Acid Induced Fluorescence Is a Powerful Intraoperative Marker for Precise Histopathological Grading of Gliomas with Non-Significant Contrast-Enhancement
por: Widhalm, Georg, et al.
Publicado: (2013)

Clinical applicability of miR517a detection in liquid biopsies of ETMR patients
por: Madlener, Sibylle, et al.
Publicado: (2023)

ATRT-07. CLINICAL APPLICABILITY OF C19MC MIRNA DETECTION IN LIQUID BIOPSIES OF ETMR PATIENTS
por: Madlener, Sibylle, et al.
Publicado: (2023)

Molecular biology of high-grade gliomas: what should the clinician know?
por: Hofer, Silvia, et al.
Publicado: (2014)

Galectin‐1 Is Implicated in the Protein Kinase C ε/Vimentin‐Controlled Trafficking of Integrin‐β1 in Glioblastoma Cells
por: Fortin, Shannon, et al.
Publicado: (2008)

Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
por: Zappe, Katja, et al.
Publicado: (2023)

Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma
por: Mair, Maximilian J., et al.
Publicado: (2021)

Extensive subdural spread of a glioblastoma associated with subdural hygroma: case report
por: Mikhalkova, Agdaliya, et al.
Publicado: (2020)

Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma
por: Preusser, Matthias, et al.
Publicado: (2014)

p53 Loss Mediates Hypersensitivity to ETS Transcription Factor Inhibition Based on PARylation-Mediated Cell Death Induction
por: Dinhof, Carina, et al.
Publicado: (2020)

Prognostic impact of genetic alterations and methylation classes in meningioma
por: Berghoff, Anna S., et al.
Publicado: (2022)

Perioperative imaging in patients treated with resection of brain metastases: a survey by the European Association of Neuro-Oncology (EANO) Youngsters committee
por: Kiesel, Barbara, et al.
Publicado: (2020)

Response to imatinib as a function of target kinase expression in recurrent glioblastoma
por: Hassler, Marco Ronald, et al.
Publicado: (2014)

Preoperative Diffusion-Weighted Imaging of Single Brain Metastases Correlates with Patient Survival Times
por: Berghoff, Anna Sophie, et al.
Publicado: (2013)

Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors
por: Berghoff, A S, et al.
Publicado: (2012)

Enhanced expression of autophagy‐related p62 without increased deposits of neurodegeneration‐associated proteins in glioblastoma and surrounding tissue – An autopsy‐based study
por: Klotz, Sigrid, et al.
Publicado: (2022)

Influence of preoperative corticosteroid treatment on rate of diagnostic surgeries in primary central nervous system lymphoma: a multicenter retrospective study
por: Scheichel, Florian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_phq861svulirpekm4qdcpbs4hv